Introduction
Insulin and insulin-like growth factor 1 (IGFI) are structural!y related peptide~ whose functions are thought to have diverged during evolution. In general, insulin functions as an endocrine hormone which is critical in the control cf eai'bohydrate, protein and lipid homeostasis. In contrast, IGFI is classically considered a regulator of cellular growth and differentiation. Interestingly, however, in certain tissues the two peptides can also mediate similar cellular effects such as the stimulation of substrate and ion transport [1] [2] [3] and cellular proliferation [4] [5] [6] [7] [8] .
Each peptide binds with high affinity to distinct receptors and it is this specific ligand-receptor interaction which initiates the physiological effects of the Abbreviations: IGFI, insulindike growth factor h MCT cells, murine proximal tubule cell line; PAGE, polyagrylamide gel electrophoresis; SDS. sodium dode~l sulfate. peptide. Overall the: insulin and tUFt receptors share remarkable homology both in primary structure and in organization. Not surprisingly, therefore, insulin and IGFl exhibit crossover binding to the heterologous receptor, however, crossover binding occurs with a significant (10-100-fold) decrease in affini~ [3, [9] [10] [11] . The crossover binding phenomenon is often evoked to explain an apparent crossover in physiological effect. For example, insulin is a required component for growth of mammalian cells which are maintained in tissue culture using serum-free, defined media. Typically the growth-stimulatory effects of insulin are achieved at pharmacologic concentrations (1 ~g/ml or greater) [12] [13] [14] [15] [16] [17] [18] . In contra~t, the effecls of IGFI on cellular proliferation are often manifested at much lower ti.e., physiological) concentrations [2, 9, 11 ] . These findings suggest that the growth stimulatory effects of both insulin an/ IGFI are manifested via binding to the IGFI receptor. In contrast, several recent studies have suggested that in certain fibroblastic cell types both insulin and IGFI can modulate cell growth via binding to their homologous receptors [5] .
lnsutin and ~3F! receptors co-exi,,t on the same cells in many tissues. In the maa~m:~lian kidney, both receptors have been demonstrated on glomerular mesangial cells [2] and proximal tubular epithelial cells [19, 20] . In addition, in renal tissue, both insulin and IGF1 have been demonstrated to stimulate solute and fluid reabsorption [3, [21] [22] [23] as well as promote growth in cell culture [24, 25] . The co-existence of two receptors, each capable of binding either ligand, necessitates a careful correlation of binding affinities with physiological effect before a functional response can be ascribed to activation of either receptor.
In this study we used a proximal tubule cell line to test whether cellular proliferation is modulated by ligand binding to insulin and/or IGFI receptors. The mouse cortical tubule (MCT) line was originally derived from microdissected proximal tubule segments from normal mice, immunoselected into a homogeneous cell populat,.'or, and stabilized in long-term culture by SV40 transformat],_,n [26]. This is a well characterized cell line which has proveu to be a good model in which to investigate growth of proximal tubule cells under a variety of metabolic [27, 28] and hormonal conditions [29] . Portions of this work have been presented in abstract form: Blazer-Yost, B.L., Watanabe, M., Haverty, T. and Ziyadeh, F.N. 11990) J. Am Soc. Nephrol. 1,453A.
Materials and Methods
Media for cell culture were obtained from Gib,.-o (G~aud island, NY). Recombinant human IGF1 (THR-59) was purchased fr._,,n.. AMGer.. Biologicais (Thousand Oaks, CA). IGFI stock solutions (#M) were prepared in 0.01 M HCI and stored at 5°C. IGFI was iodinated to a specific activity of 1600-2300 Ci/mmol using a modified chloramine-T procedure [30] . Porcine insulin was kindly provided by Lilly Research (Eli Lilly, Indianapolis, IN). Insulin stock soiutions (raM) were prepared in 0.0{)5 M HCI and stored at 5°C. ~251-1abeled porcine inst, lin, 2200 Ci/mmol, was purchased from New England Nuclear (Boston, MA).
[3H]Thymidine, 5 Ci/mmol, was obtained from Amersham (Arlington Heights, IL). Disuccinimidyl suberate was obtained from Pierce Chemical (Rockford, IL). Disuccinimidyl suberate stock (5.10 -3 M) was prepared in DMSO immediately before use. Electrophoresis grade reagents for polyacrylamidc gel electrophoresis (PAGE) were purchased from Bio-Rad (Richmond CA). All other reagents were highest quality available and were obtained from commercial sources.
Cell Cultltre. The isolation and characterization of the MCT cell line were provided previously [26] . Multiple morphological and functional properties of this cell line are consistent with those of differentiated proximal tubule epithelial cells [26] [27] [28] . Briefly, the ceils stain positive for cytokeratin and alkaline phosphatase and demonstrate apical microvilli and lateral tight junctions by electron microscopy. The cells respond to treatment with parathyroid hormone by an increase in cyclic AMP content [29] . In the studies described here, the culture medium was a 1 : 1 mixture of Dulbecco's modified Eagle's medium (DMEM) and Ham's-Fl2 (HFI2), supplemented with 100 /zg/ml streptomycin, 100 U/ml penicillin, 2 mM glutamine and 5 #.g/ml human transferrin. The cells were passaged every 48-72 h and were carried in culture medium supp!emented with 10% inactivated fetal calf serum. Cultures were maintained in a humidified atmosphere of 5% CO 2 at 37°C.
Competitire binding studies. In .:hose experiments where competitive binding of insulin and 1GF1 to MCT cells was determined, the cells were seeded onto 24 well tissue culture plz~tes (density= 10 "~ cells/well). The cells were maintained in normal media for 24 h, then placed in serum-free media for 24-48 h prior to assay. Confluent cellular monolayers were washed and incubated at room temperature for 90 rain in bindi,ig buflX:r (serum-free medium, 0.2% BSA, 25 mM Hepes, pH 7.4) containing (3-4)-10 -"~ M [~2Sl]insulin or [I~Sl]IGFI and unlabeled competing peptides as indicated. At the end of the incubation period, the cells were washed three times with ice-cold phosphatebuffered saline and solubilized in 1 M NaOH, 0.1% Triton X-100. Aliquots of the solubilized cellular material were counted in a gamma scintillation cout:ter. Nonspecific binding was defined as the number of counts bound in the presence of 10 -7 M unlabeled peptide and this value was subtracted from all samples. In every experiment duplicate or triplicate assay wells were performed for each concentration. Nonspecific binding was less than 20% of total binding.
To further define the binding specificities of the receptor subunits, cells were incubated in binding buffer with (3) (4) . I0 -I° M [t251]IGF1 in the presence or absence of unlabeled competing peptides. After a 90 min incubation period at room temperature, the cells were washed twice with cross-linking buffer (0.1 M Hepes, 0.12 M NaCI, 5 mM KCI, 1.2 mM MgSO 4, 8 mM glucose and 10 mg/ml BSA, pH 8.0). The bound peptide was covalently cross-linked to the receptor by a 15 rain incubation with 0.1 mM freshly prepared disuccinimidyl suberate in crosslinking buffer, The reaction was terminated by the addition of 0.1 M Tris (pH 8.8). The cells were washed and solubilized in SDS-PAGE buffer (3% SDS, 10% glycerol, 1% j0-mereaptoethanol, 0.05 M Tris, pH 6.8). The solubilized samples were stored at -20°C.
PAGE. SDS-PAGE was performed on 15 × 13 cm slab gels with a linear 5-15% acrylamide gradient and a 4% stacking gel. The aliquots applied to the gel were matched for cell num0er. The preparations were subjected to eleetrophoresis under constant current conditions (30 mA/gel for 20 min followed by 25 mA/gel for 4 h). The gels were then fixed, dried and exposed to Kodak XAR-5 film in cas:mttes containing X-Omatic fine intensifying screens (Eastman Kodak, Rochester, NY).
[';H]Thymidine incorporation studies. Cells in culture
were released by t~psin-EDTA, washed twice in serum-free medium and adjusted to a final concentration of 1 • 10 ~' celis/ml. 10000 cells were subcultured in fiat-bottom 96-microtiter wells, each containing 200 ~1 serum-free medium. After 48-72 h of quiescence the media were removed and replaced with fresh serumfree medium without or with the addition of various concentrations of insulin or IGFI as noted in the text. All growth studies were performed on rested cells at approx. 70% subconfluence. Cells were allowed to grow for an additional 24 h. During the last 6 h of culture, the cells were pulsed with ["q]thymidinc (1 p.Ci/well). The media were removed amt the cells were released with trypsin-EDTA for subsequent lysis and collection with a cell harvester (13randel, Gaithersburg, MD) onto glass-microfiber filter paper (934-AH, Whatman, U.K.). The incorporated radioactivity in cellular nuclei was as,~ayed by counting filters in scintillation cocktail.
[3H]Thymidine incorporation into cell DNA was take~ as an index of cell proliferation and was expressed in counts per mix per well. Each experimental condition was tested in four to six replicate wells and the mean was taken to represent an individual experiment. In parallel experiments, measurements of cell number were performed in order to verify that the observed increase in thymidine incorporation was associated ~ith an increase in cell number.
Statistics. The data are presented as means + S.E.
with n indicating the number of different experiments. Comparisons were performed using Student's t-test for paired or unpaired values as appropriate; values of P < 0.05 were considered sil~nificant. Binding studies were analyzed graphically. 
Results

Competitive binding studies
[~H]Thymidine incorporation studies
Peptide effects on cellular proliferation were determined by measuring [3H]thymidine incorporation in the presence of various concentrations of ~nsulin and IGF1 (Fig. 4) . Both insulin and IGFI stimulated th,:midine incorporation in a dose-dependent manncr with similar maximal increases above the basal level. The estimated half-maximal stimulation (ECsa) is 4 nM for IGFI and 8 nM for insulin; these concentrations fz:l within the physiologic range of either peptide.
A maximal effect of IGF1 on cellular p:oliferation appears to be manifested within a narrow concentration range. Maximal [3H]thymidine incorporation was achieved at l0 nM and further increases in peptide concentration result in a submaximal proliferative response ( Fig. 4} To confirm the ability of insulin to stimulate cell proliferation, palalld ~ubconfluent cultures in 12-well plastic plates were incubated in the presence and absence of 32 O---O. insulin; e--e, IGFI.
A S i il .. )f IGFI and insulin elicits an additive effect 'm thymidine incorporation which is significant!y (P < 0.05) higher th~:n that exhibited by either hormone alone (*). When maximal doses (;f either IGFI or insulin are combined with epidermal growth factor (EGF, lit ng/ml), the stimulation in thymidine incorporation is significantly ~P < 0. (15) higher than that exhibited by treatment with EGF alone ( + ).
We have also cxan|ined the proliferative response to incubation with combinations of insulin, 1GFI and epidermal growth factor (EGF) (Fig. 5) . Incubation with submaximal doses of IGFI and insulin (3.2 nM) resulted in a significantly higher stimulation of th~,midine incorporation compared zo that elicited by either hormone alone. In contrast, the combined treatment with maximal doses of IGF1 and insulin (32 nM) produced a proliferative stimulation that was not different from the response to either hormone alone. When maximal doses of either IGFI or insulin (32 nM) are combined with epidermal growth factor (10 ng/ml), the stimulation in thymidine incorporation was significantly higher than that exhibited by treatment with EGF alone. A combination of maximal doses of EGF and IGFI (or insulin) also stimulates thymidine incorporation to a significantly higher (P < 0.05) level than either IGFI or insulin alone (data not shown).
Discussion
In the kidney insulin is thought to modulate metabolic and transport functions while IGFI is considered to be a regulator of growth and differentiation [21, 31, 34] . Many of the studies which have given rise to this general concept have used intact organs or membranes isolated from specific areas of the kidney. While such studies have been extremely valuable in establishing the functions of various nephron segments, it is 333 difficult to precisely determine the role of growth factors and metabolic modulators in these experimental systems. A comindous cell line derived from a defined area of the kidney tubule provides the cellular homogeneity and st~tbi!i,~y necessary to assess the contribution of various fact,~rs to the growth of a specific cell type. In this study we used the MCT cell line as a model For proximal tubule ceil growth. Previous investigations have demonstrated that this cell line retains the characteristics of differentiated proximal tubule ceils and provides a suitable model to investigate proliferation of renal epithelia [26] [27] [28] [29] .
While the physiological role of insulin in renal glowth remains unclear, it is known that kidney cells in culture require insulin in the supporting medium. Hormone-supplemented, serum-free medium has been described for maintenance of the Madin-Darby canine kidney (MDCK) cell line [12] , the LLC-PKI epithelial cell line from pig kidney [15] , and for primary cultures of canine renal epithelia [13] , baby mouse kidney cells [14] and rabbit kidney epithelial cells [16, 17] . IGFI was not a component of the hormone supplements but insulin was present in micromolar concentrations, l'he assumption, explicit or implicit, is that -".t these supraphysiological concentrations insulin modulates growth and differentiat;on via crossover binding to IGFI receptors. However, this assumption may not be valid for all cell types.
Physiological concentrations of either insulin or IGFI promote cell growth and proliferation via bindin': to their homologous receptors in a rat osteosarcoma cell line, UMR-106-01 [8] and in Swiss 3T3 fibroblasts [6] as well as in normal skin fibroblasts i~ primary [4] and continuous [7] culture. In a careful stlidy, Furlanctt6 ct ai. [5i used specific anti-receptor ant!bodies to show that insulin, working via an insulin receptor, was not mitogenie in two lines ef human embryonic lung fibroblasts but, under identical conditions, was milogenic in a human dermal fibrobiast cell line, a human embryonic skin fibroblast line and an osteogenic sarcoma cell 1inc. Thus, it appears that, altlaough activation of IGFI receptors is uniformly capable of mediating a mitogenic response, the ability of activated insulin receptors to stimulate proliferation is cell-specific.
Both insulin and IGFI receptors have previously been demonstrated on proximal tubular epithelia [19, 20, 32] . In agreement with these studies, we have found that mouse proximal tubule cells in culture also contain two separate receptors, each with similar displacement curves (Figs. 1 and 2 ). The affinity of insulin for the insulin receptor is very similar to that of IGFI for the IGFI receptor; crossover binding does occur but only with 10-100-fold lower affinity. The displacement curves for insulin and IGFI binding to their specific receptors are very similar to those reported in other tissues and cell lines [2, 3, 11, 33] . Insulin/IGFl hybrid receptors have been assembled in vitro [35] and !lave been identified ~n NIH3T3 and HepG2 cells [36] and in transt'ec'~ed rodent cells which overe;~press human insulin and IGFI receptors [37] . Our binding curves are consistent with the exist~tnce of separate insulin and IGFI receptor populations, howcver, we cannot rule out the existence of a small number of insulin/IGF receptor hybrids. The molecular weight of the a subunit of MCT cell IGFI receptor is comparable to other IGFI receptors [38] and the ligand binding specificity is manifested at the level of the. ot subunit (Fig. 3) .
In our studies the amount of IGFI specifically bound by the proximal tubule cells was at least an order of magnitude greater than that of insulin indicating a relatively higher number of IGFI receptors. This is similar to isolated rat renal tubules [33] and cultured rat renal mesangial cells where specific binding of [1251]IGFI was > 200-fold higher than insulin binding [2] . in contrast, the specific binding of insulin was approx. 4-fold higher than that of IGFI in proximal tubular basolateral membranes prepared from canine kidneys [32] . It is unknown whether the differences in magnitude of receptor expression in the proximal tubule represents natural differences in species, heterogeneity in cell type found in intact kidney or changes in receptor expression during the process of cellular immortalization.
Both insulin and IGFI stimulate [3H]thymidine incorporation iv proximal tubule cells with an ECs, between 3 and 10 nM; a maximal dose of IGFI stimulated thymidine incorporation 2.2-fold, while a maximal concentration of insulin eliciled a 2-told stimulation. A comparison of the receptor-ligand binding affinities ( Figs. 1 and 2 ) with the dose-response relationships for [3H]thymidine incorporation (Fig. 4) reveais that each growth factor appears to stimulate growth via binding to its own reeeptt~r. Therefore, in this proximal tubule cell line, physiologic concentrations of either insulin or IGFI can modulate <ellular growth. It is possible that the slightly higher pntency and magnitude of stimulation by !GFI is due to the higher density of the IGFI receptor compared with that of the insulin receptor.
To our knowledge this is the first demonstration of a mitogenic effect which may be modulated by ligand binding to the insulin receptor in proximal tubule epithelia. Very little, in general, is known regarding growth effects of insulin on epithelial cells. In contrast, IGFl has been implicated as a major growth factor in re~al tissue. Renal hypertrophy is a manifestation of acromegaly [39] which is characterized by an increase in circulating IGFI levels, in addition, in response to certain stimuli, such as the loss of renal mass, the cortical attd medullary collecting duct cells of the mammalian kidney are known to synthesize IGFI [34, [40] [41] [42] .
The demonstration of specitic receptors fnr IGFI in the proximal tubule support the concept of a paracrlne 'loop' for IGFI [34] .
Interestingly. maximal sthnulation of [3H]thymidine incorporation occurs at all insnlin concentrations measured at and above 32 riM, whereas IGFI is only maximally effective over a very narrow concentration range. A similar sharp decrease in the magnitude of 1GFI stimulation of [3H]thymidine incorporation at peptide levels above 10 nM has been demonstrated in cultured rat renal mesangial cel!s [2] . This relatively narrow effective concc~,tration range may be physiologically relevant. However, a complete understanding of this phenomenon is limited by imprecise measurements of effective in vivo concentrations of IGFI.
In vivo, insulin levels in the circulation vary widely and rapidly according to the metabolic requirements of the organism. Despite this fluctuation, the effective circulating concentration o! insulin is known to be much lower ~han the total concentration of IGFI. IGFI, unlike insulin, is bound by several high affinity, soluble binding proteins which may modulate pcptide-receptor interactions and, therefore, the ef-,¢eetive circulating concentration is difficult to ascertain [11, 31] . Also, in contrast to insulin, IGFI is a paraetine or autoerine factor in the kidney [34] .
Although the growth stimulator,/responses to both in~,i:,i and IGFI appear to be initiated by ligand binding to distinct receptors, the cascade of events that culminate in cell proliferation may overlap at a point subsequent to ligand-reeeptor binding. The stimulatory response to a combination of maximal concentrations of both insulin and IGFI is not statistically greater than the response to a maximal stimulation of either peptide alone (Fig. 5) . This was not due to the inability of the epithelium to show a further increase in thymidine incorporation: a maximal concentration of EGF in combination with a maximal concentration of insulin stimulates MCT cells to a greater degi-ee than either peptide alone.
A similar overlap in the intracellular pathways stimulated by insulin and IGFI has been observed in the toad urinary bladder, a model of the mammalian distal nephron [3] . In this high resistance epithelium insulin or IGFI binding to distinct receptors stimulates .~ran-scellular Na + flux. The natriferic pathways activated by insulin and IGFI appear to converge subsequent to ligand-receptor binding but prior to the final transport stepts). The ~enerality of this post-receptor convergence in intraeellular pathways remains to be tested.
The role of IGFI as a renal growth factor has been delineated by various studies; the role of insulin in renal growth remains more elusive. The current data suggest that insulin may be an important factor in renal cell proliferation. This peptide may play a role in repair and recovery after insult or may be important as a maintenance fa~.tor during normal epithcliz'{ turnover and regeneration; however, the exact functi(,a o~. insulin-stimulated proliferation remains to be :tt: , ted.
